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Some latex house paints release dangerous levels o f mercury vapor. Check the label. 
Latex paints sold after August 1990 must carry a warning if  they contain a mercury 
additive.
A recent study by the National Institutes o f  Health indicates that the small amounts 
of mercury released in the mouth by dental amalgams pose no known danger to 
health.
Because mercury has several forms and produces subtle effects at chronic low-level 
exposures, mercury toxicity can be a difficult diagnosis to establish.
This monograph is one in a series o f self-instructional publications designed to increase the prim ary care 
provider's knowledge o f hazardous substances in the environment and to a id  in the evaluation o f potentia lly  
exposed patients. See page 23 for further information about continuing medical education credits and continuing 
education units.
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How to use this issue...
This issue begins with a composite case study that describes a realistic encounter with a patient. This description 
is followed by a pretest. The case study is further developed through Challenge questions at the end of each section. 
To benefit fully from this monograph, readers are urged to answer each question when it is presented. (Answers to 
the Pretest and Challenge questions are found on pages 21-2.) The monograph ends with a posttest, which can be 
submitted to the Agency for Toxic Substances and Disease Registry (ATSDR) for continuing medical education 
(CME) credit or continuing education units (CEU). See page 23 for further instructions on howto receive these credits.
The objectives of this monograph on mercury are to help you:
□  Explain why mercury may be an acute and chronic health hazard
□  Describe the known factors contributing to mercury toxicity
□  Identify potential environmental or occupational sources of exposure to mercury
□  Identify evaluation and treatment protocols for mercury exposure
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Case Study
A 3-year-old boy with irritability, digital erythema, and leg pain
A 3-year-old boy is brought to your office by his parents, who state that the child refuses to play and prefers to lie 
on his bed. His parents note that about a month ago, he seemed to withdraw and become cranky. Recently, he 
has experienced night sweats. On those nights the child has felt warm, but his parents did not take his temperature. 
The child has had no other symptoms, such as a runny nose or cough, and has not lost weight.
History reveals that the patient had recurring ear infections this past winter, which were treated with oral antibiotics. 
His growth and development have been normal; he is in the 90th percentile for weight and height. The child's 
immunizations are up to date, and he is on no medications.
During physical examination, the boy is uncooperative and crying. He refuses to walk or stand and says that his 
legs "hurt." He is afebrile, has a heart rate of 130 per minute and respirations of 16 per minute. He is sweating, 
and his nose, fingers, and toes are erythematous; the skin on his fingers and toes is peeling. The oral pharynx and 
abdomen appear normal upon examination; his lungs are clear. He does not have point tenderness in his legs, 
and he has full range of motion in knees and hips. His ankles are not edematous. Results of the neurologic 
examination are normal; there is no muscular atrophy. Other findings are unremarkable.
Three months ago, the child, his parents, and his 6-year-old sister moved into a freshly painted house. The parents 
report that their daughter appears healthy and is doing well in first grade. Both parents are school teachers in good 
health. The family has no pets and has not traveled within the past year. Until recently, the boy has enjoyed most 
social activities with his family.
(a) What should be included on the patient's problem list?
(b) What is the differential diagnosis for this patient?
(c) What tests would you recommend to confirm or rule out a diagnosis?
(d) What treatment and followup would you recommend?
Answers can be found on pages 21-2.
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Exposure Pathways
□  Elemental mercury vapor 
accounts for most occupa­
tional and many accidental 
exposures.
□  The major source of organic 
methylmercury exposure in 
the general population is fish 
consumption.
□  Mercury-containing dental 
amalgams have not been 
proven to cause adverse 
health effects.
Mercury (Hg) is a metal found in the environment in its elemental 
state and as organic and inorganic compounds. For 3000 years, 
mercury, in various forms, has been used in medicine and industry. 
Although most medicinal uses have been discontinued, industrial 
uses of mercury are increasing.
Mercury exists in three forms: elemental mercury (Hg°), inorganic 
mercury salts (Hg1+ and Hg2+), and organic mercury. Elemental 
mercury is a silver-gray liquid at room temperature that vaporizes 
readily when heated. Commonly referred to as quicksilver or metallic 
mercury, it is used in thermometers, thermostats, switches, barome­
ters, batteries, and other products. Elemental mercury vapor ac­
counts for most occupational exposures.
The intermediate oxidation state, Hg1+, forms numerous mercurous 
salts; the best known is mercurous chloride or calomel, which was 
commonly used in teething powders and other medicines until its 
adverse effects were publicized in 1948. The highest valence state, 
Hg2+, forms a variety of mercuric salts, which are used to inhibit 
bacterial or fungal growth. Most mercurous and mercuric salts 
readily disassociate into ions in the body.
Under appropriate conditions, Hg2+ can covalently bind carbon to 
form organomercury compounds; the most important in terms of 
human exposure is methylmercury (MeHg). MeHg is the form most 
frequently involved in mercury food poisoning. Elemental mercury 
and MeHg compounds have a greater ability to cross cell mem­
branes than do the mercurous or mercuric salts and are conse­
quently more neurotoxic than mercury salts.
The major source of atmospheric mercury is the global off-gassing 
of mercury from soils and surface waters. Burning of fossil fuels, 
particularly coal, contributes to the level of mercury in the atmos­
phere. The airborne level is increased by disposal of solid waste 
(e.g., thermometers, electrical switches, and batteries) in landfills; 
application of mercury-containing paints, fungicides, and pesticides; 
and combustion of waste oils.
Weathering of mercury-bearing rock and industrial effluents are the 
major sources of mercury contamination in water. Elevated mercury 
concentrations have been detected in approximately 25% of the 
groundwater and surface-water samples from 2783 hazardous 
waste sites tested by the Environmental Protection Agency (EPA). 
Groundwater surveys also have detected elevated mercury concen­
trations in some drinking-water supplies. Industrial processes that 
may produce mercury-containing effluents include chlorine and 
caustic soda production, mining and ore processing, metallurgy and
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electroplating, chemical manufacturing, ink manufacturing, paper 
milling, leather tanning, textile manufacturing, and pharmaceutical 
production.
Any mercury compound released into the environment becomes 
available for potential methylation to MeHg by microorganisms 
indigenous to soils and waters. Higher methylating rates are asso­
ciated with acidified waters. MeHg in surface waters rapidly accumu­
lates in fish and other aquatic organisms. The mercury concentration 
in fish at the top of the food chain is typically biomagnified up to 
100,000 times the concentration in surrounding waters.
In the general population, diet is the major source of mercury 
exposure, primarily through fish consumption. Predacious fish (e.g., 
pike in freshwater, tuna and swordfish in marine water) can have 
more than 50 times the average mercury concentration found in most 
other fish. Between 70% and 90% of the total mercury detected in 
fish is in the form of MeHg. The U.S. Food and Drug Administration 
(FDA) is responsible for regulating commercial fish. Regulations 
require that marketed fish contain no more than 1 part per million 
(ppm) of mercury. Many states have lower advisory levels for sport 
fish. Other potential sources of dietary exposure are the consump­
tion of fish-eating birds and mammals and consumption of game 
birds in areas where mercury-containing pesticides have been used. 
During the winter of 1971-72, thousands of Iraqis were poisoned by 
consuming homemade bread prepared from seed wheat that had 
been treated with a MeHg fungicide.
According to EPA, approximately 30% of interior latex paint manu­
factured before 1990 contained mercury compounds to prevent 
bacterial and fungal growth. In 1989, a case of acrodynia (a rare 
disease in children caused by mercury; see page 13) in a 4-year-old 
boy occurred 10 days after the child’s home was painted with a 
mercury-containing interior latex paint and was not ventilated. Mer- 
cury-containing paint can raise the total indoor air mercury concen­
tration by 1000 times the level before painting. Paint manufacturers 
agreed to stop using mercury in interior paint after August 20,1990; 
however, sale of existing stocks of interior latex paints was allowed 
until July 1991. Paint manufacturers also have agreed to place labels 
on mercury-containing exterior paint with a warning that the paint is 
for outdoor use only. Mercury use in exterior paint was discontinued 
after September 1991. Mercury-containing joint compound, plas­
ters, and adhesives must be labeled appropriately; sale to distribu­
tors was allowed until June 1991. Because many people keep partly 
used cans of paint for repainting, pre-1990 paints may continue to be 
a source of mercury exposure for years.
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Medical treatments and some cosmetics constitute another source 
of potential mercury exposure. Mercurials have been used for 
hundreds of years for a variety of therapeutic purposes including 
cathartic, diuretic, antisyphilitic, antiseptic, antipruritic, anti-inflam­
matory, antiparasitic, and vermifuge. Metallic mercury has been 
used by Mexican-American and Asian populations in folk remedies 
for chronic stomach disorders and by Latin-American and Caribbean 
natives in occult practices. Mercurials are still used as preservatives 
in some eye drops, eye ointments, nasal sprays, vaccines, and as 
antiseptics and diuretics. Gammaglobulin preparations contain 
Merthiolate™*, a mercury-containing biocide. Elemental mercury in 
a Miller-Abbott tube, which is used for intestinal decompression, 
provides the weight that assists the tube in traversing the Gl tract.
Silver dental amalgams, which have been used for the past 150 
years to fill cavities in teeth, can be 50% elemental mercury by 
weight. About 200 million mercury restorations are performed in the 
United States each year; at least one-half of those use silver 
amalgam. The mechanical action of chewing on an occlusive filling 
releases trace quantities of mercury vapor, which are partially 
absorbed. Typically, exposure to mercury from amalgams is less 
than exposure from foods such as tuna or swordfish that contain 
MeHg, a more toxic form of mercury. It is estimated that people with 
many amalgam fillings receive less than 1% of the daily mercury 
vapor dose that is considered occupationally safe. A National 
Institutes of Health expert panel recently concluded that amalgam 
fillings pose no significant risk of side effects and should not be 
replaced simply because they contain mercury.
* Use of trade names is for identification only and does not imply endorse­
ment by the Public Health Service or the U.S. Department of Health and 
Human Services.




A 1980 survey by the National Institute for Occupational Safety and 
Health (NIOSH) estimated that 70,000 workers, of whom about one- 
third were women, were potentially exposed to mercury (p rim arily  
m ercury vapor) in the w orkp lace . M ost of these w orkers were 
em ployed as labora to ry  techn ic ians, reg is te red  nurses, and 
machine operators. Household members of occupationally exposed 
workers may also be at increased exposure risk because mercury 
can be brought into the home on contaminated clothes.
Personnel potentially exposed to mercury include, but are not limited
to, the following:






felt makers and leather tanners
grinding machine operators
hazardous waste site personnel
ink manufacturers
laboratory personnel
manufacturers of batteries, fluores­
cent lamps, mercury vapor lamps, 
switches, rectifiers
metallurgists
m iners and processors of cinnabar 
(HgS), gold, silver, copper, zinc
paint and pigment manufacturers
painters
paper millers




Fetuses, infants, and children are at increased risk of adverse effects 
of MeHg. MeHg readily crosses the placenta during the prenatal 
stage, when the nervous system is most sensitive to mercury 
poisoning. Because MeHg concentrates in breast milk, nursing 
infants can be affected.
Children are attracted to the appearance and unique properties of 
liquid elemental mercury and are at risk of ingesting elemental 
mercury, as well as mercury-containing dust and soil, because of 
natural mouthing behaviors. Infants and children are at increased 
risk of inhaling elemental mercury because mercury vapor is heavier 
than air and tends to settle to the floor.
□  Workers using mercury or 
mercury-containing prod­
ucts, as well as their house­
hold members, may be at 
increased risk of exposure to 
mercury vapor.
□  Fetuses, infants, and chil­
dren are at greatest risk of 
MeHg's adverse effects.
□  Children are at increased risk 
of exposure to elemental 
mercury vapor in the home 
because mercury vapor 
tends to settle to the floor.
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Because many people are increasing their consumption of fish in an 
effort to lower blood cholesterol concentrations, mercury exposure 
through diet may be increasing. Mercury is a contaminant of many 
fresh and marine waters. In the 1950s, hundreds of people were 
mercury-poisoned in Japan after consuming fish from Minamata 
Bay. The incident caused 41 deaths and at least 30 cases of infantile 
cerebral palsy. The source of contamination was effluent discharged 
into the bay from a factory using a mercury catalyst to make vinyl 
chloride.
Neurologic and behavioral disorders have been observed in persons 
after ingestion or dermal application of inorganic mercury-containing 
compounds in teething powders, skin-lightening ointments, and 
laxatives. Most of these products have been withdrawn from the 
market or are no longer available in the United States. Yellow 
mercuric oxide reportedly caused acrodynia (see Signs and Symp­
toms) in a 4-month-old boy being treated for eczema. Long-term 
abuse of a mercury-containing laxative was the cause of death in at 
least one patient.





Mercury's absorption and metabolism depend on its chemical and 
physical form. Inhaled as a vapor, elemental mercury is almost 
completely absorbed (about 80%) and diffuses rapidly across the 
placental and blood-brain barriers (Table 1). At the cellular level, 
dissolved vapor is oxidized to Hg2+. Ethanol, even at nonintoxicating 
levels, inhibits mercury oxidation in the blood and prolongs elemen­
tal mercury's half-life in the body.
The chemical and physical 
forms of mercury determine 
its absorption, metabolism, 
distribution, and excretion 
pathways.
When ingested, elemental mercury is poorly absorbed from the 
gastrointestinal tract (about 0.01%). The surface of the metal prob­
ably becomes coated rapidly with endogenous sulfur-laden com­
pounds, which impairs diffusion across the gastrointestinal mucosa. 
A 17-year-old boy reportedly ingested 204 grams (g) of elemental 
mercury without systemic toxicity. Animal studies indicate that 
elemental mercury as a liquid or vapor can be absorbed percutaneously.
Elemental mercury is almost 
completely absorbed when 
inhaled, but poorly absorbed 
when ingested. It readily 
crosses the biood-brain bar­
rier.
Table 1. Clinical importance of various forms of mercury




Liquid Hg1 Hg° Thermometers,
barometers





Hg° Industrial Inhalation: 80% absorbed 





Mercurous H g'+ Medicines,
antiseptics
Ingestion: -10%  absorbed 












Ingestion: 80%-100% absorbed 
Dermal contact: See Salts above
Kidneys CNS
* In humans, the biologic half-life of all forms of mercury is 40 to 70 days. 
f Crosses the blood-brain barrier.
§ Liquid elemental mercury is poorly absorbed through the intestinal tract (0.01%) or dermally; systemic toxicity is rare. 
1 CNS = central nervous system; Gl tract = gastrointestinal tract
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□  Mercuric salts are generally 
more toxic than mercurous 
salts.
□  Mercury salts do not cross the 
blood-brain barrier as readily 
as elemental mercury does.
Q  Organomercurials are
absorbed well regardless of 
exposure route.
□  MeHg concentrates mostly in 
the blood and brain.
The urine and fecal elimination pathways account for most of the 
excretion of elemental mercury. Exhalation of mercury vapor and 
secretion of mercuric ions in saliva and sweat contribute to the 
elimination process. The biologic half-life of inhaled elemental mer­
cury in humans is approximately 60 days.
Mercury salts
On average, less than 10% of an ingested mercury salt is absorbed 
from the gastrointestinal tract. Dermal absorption of ionic mercury 
salts also can cause toxicity. In general, mercuric (Hg2+) salts are 
more soluble and produce more serious poisonings than mercurous 
(Hg1+) salts. Mercuric salts are usually colorless or white crystals or 
intensely colored yellow or red powders; they include mercuric 
chloride (antiseptic and disinfectant), mercuric cyanide and mercuric 
oxide (topical antiseptics), and mercuric nitrate (used in working with 
felt). Mercurous salts are typically colorless, white, or light yellow 
powders; they include mercurous acetate (antibacterial agent), 
mercurous chloride or calomel (cathartic, diuretic, antiseptic, and 
antisyphilitic agent), mercurous nitrate (used to blacken brass), and 
mercurous oxide (used to make electric batteries).
The tissue distribution and excretion pathways of mercury salts are 
similar to those of mercury vapor; however, mercuric and mercurous 
ions cross the blood-brain and placental barriers to a much lesser 
extent than inhaled elemental mercury. In humans, mercury salts 
have a shorter biologic half-life (about 40 days) than inhaled elemen­
tal mercury.
Organic mercury
Organomercury compounds are readily absorbed by inhalation, 
dermal contact, and ingestion. MeHg is distributed uniformly to all 
tissues, although it concentrates more in the blood and brain than 
elemental mercury or mercury ions do. About 90% of MeHg is found 
in the red blood cells, where it is metabolized to mercury ions at a 
slow rate. The major route of MeHg excretion (about 90%) is through 
bile into the feces; urinary excretion accounts for most of the 
remaining 10%. The biologic half-life of MeHg is about 70 days in 
humans.
Although considered organomercurials, phenylmercury compounds 
are absorbed less efficiently by the gastrointestinal system than 
MeHg compounds. Because phenylmercury is rapidly metabolized 
in the body to Hg2+, its effects are similar to those of mercury salts. 
Metabolites of phenylmercury are excreted mainly in the urine.
Mercury Toxicity
Physiologic Effects
Effects of mercury toxicity manifest primarily in the central nervous 
system (CNS) and kidneys, where mercury accumulates after expo­
sure. The duration, intensity, and route of exposure, and the form of 
mercury influence which systems are affected. The primary organ 
system affected by chronic exposure to elemental mercury and 
organomercury compounds is the nervous system; the primary 
organs affected by chronic exposure to mercury salts are the 
kidneys. In acute poisonings, the respiratory system is affected by 
inhaled elemental mercury and the gastrointestinal system by in­
gested mercury salts. The cardiovascular system may be affected 
secondarily.
The precise mechanism of action for all forms of mercury is unclear. 
Mercury ions (Hg1+ and Hg2+) alter the structure and function of 
enzymes and other proteins by binding to sulfhydryl groups. Mercury 
may also interfere with cellular metabolism by binding to amine and 
phosphoryl groups. MeHg and high levels of inhaled elemental 
mercury are able to cross the blood-brain and placental barriers. In 
humans, MeHg exposure has resulted in pronounced adverse 
neurologic effects in the fetus. The effects of elemental mercury on 
the human fetus have not been studied thoroughly.
Neurologic Effects
CNS effects result primarily from exposure to elemental mercury 
vapor and to MeHg. These forms of mercury cross the blood-brain 
barrier readily and can produce irreversible brain damage. MeHg 
ingestion leads to delayed CNS symptoms that may not manifest 
until months after the initial exposure, and early symptoms are often 
nonspecific, such as malaise, blurred vision, or hearing loss. The 
peripheral nervous system also may be affected. Some investigators 
suggest that alteration in neurotransmission may be one mechanism 
of action for mercury-induced neurotoxicity.
Renal Effects
After inorganic salts or phenylmercury compounds are ingested, a 
large amount of mercury may accumulate in the kidneys, producing 
a generalized increase in the permeability of the tubular epithelium. 
Exposure to mercury vapor or to mercury salts produces an appar­
ently dose-dependent proteinuria or nephrotic syndrome. Acute 
tubular necrosis with resultant renal failure may occur.
□  The central nervous system 
and kidneys are key targets of 
mercury toxicity.
□  In acute poisonings, 
the respiratory and 
gastrointestinal systems 
can be affected.
□  MeHg and inhaled elemental 
mercury accumulate rapidly in 
the CNS.
□  Severe renal damage can 
result from ingestion and 




Evidence indicates that MeHg 
causes developmental effects.
Data are limited on the fetal 
effects caused by forms of 
mercury other than MeHg.
Studies of MeHg concentrations in the blood of newborn infants 
show a significant correlation with maternal blood levels. In MeHg 
poisonings, damage to the fetal nervous system is widespread and 
probably involves derangement of developmental processes such 
as neuronal migration and neuronal cell division. MeHg also may 
have a high affinity for fetal hemoglobin. Infants born to women who 
had ingested flour made from grain treated with a MeHg fungicide 
had brain damage manifested by mental retardation, ataxia, deaf­
ness, constriction of the visual fields, blindness, microcephaly, 
cerebral palsy, and disturbances in swallowing. In experimental 
animals, exposure to elemental mercury vapor or administration of 
mercury salts has produced developmental anomalies, but the 
relevance of these findings to humans is unknown.
Other Effects
Severe tissue damage to the 
lungs (through inhalation 
exposure) and Gl tract 
(through ingestion expo­
sure) has been reported.
Respiratory and gastrointestinal effects can occur in acute mercury 
poisonings. Inhalation of elemental mercury has caused severe 
pulmonary tissue damage; autopsy has revealed dilation of the right 
ventricle due to respiratory failure in children who died from mercury 
vapor inhalation. Gastritis and necrotizing ulceration of the intestinal 
mucosa can result from ingestion of inorganic salts. Liver damage 
also has been reported in cases of poisoning due to mercury salts. 
Both increased and decreased blood pressure have been associ­
ated with elemental mercury exposure.
Chromosomal aberrations have been found in some persons work­
ing with mercury. There is insufficient evidence to associate mercury 
with cancer in humans.
Challenge
(3) Additional information for the case study: The patient's mother is 2  months pregnant. Is the fetus at 




History and Physical Examination
A complete history of a patient with possible mercury toxicity should 
contain the following information:
• occupation and hobbies of all home occupants.
• recent application of mercury-containing caulks, latex paint, and other
materials in constructing or renovating homes and other buildings.
• recent move. Previous tenants may have spilled mercury, or the new
home recently may have been painted with mercury-containing 
paint.
• use of folk medicines. Mercury compounds have been detected in
folk and nontraditional healing medications.
• use of cosmetics. Mercury is contained in some mascaras and wave
fixatives, and some skin lighteners sold outside the United States.
• use of over-the-counter preparations such as nasal sprays, contact
lens solutions, and topical antiseptics.
• source and amount of fish consumed per week.
• use of elemental mercury in a school laboratory.
• playing with mercury. Children are attracted to liquid elemental
mercury because of its unique properties.
The nervous system and kidneys should be carefully examined. 
Recent behavioral changes, such as an increase in irritability or 
shyness and changes in short-term memory, should be docu­
mented. In children, developmental milestones should be evaluated. 
Blood pressure and liver function also should be assessed. If 
mercury salts have been ingested and corrosive injury is suspected, 
endoscopic examination should be performed. If elemental mercury 
vapor has been inhaled, a chest X ray should be obtained.
Signs and Symptoms 
Acute Exposure 
Elemental Mercury
Inhalation of elemental mercury vapor may rapidly produce cough, 
dyspnea, chest pain, nausea, vomiting, diarrhea, fever, and a 
metallic taste in the mouth. Stomatitis, colitis, nephrotic syndrome, 
and salivation may occur. Later, interstitial pneumonitis, necrotizing 
bronchiolitis, and pulmonary edema may develop. According to one 
case report, a person experienced symptoms characteristic of 
amyotrophic lateral sclerosis after an intense elemental mercury 
vapor exposure; symptoms abated as the body burden of mercury 
decreased. Children less than 30 months of age appear to be at 
increased risk for pulmonary toxicity, and death may rapidly result
□  A com plete history and 
careful evaluation of the 
nervous system and kidneys 
are essential in diagnosing 
mercury toxicity.
□  Pulmonary and CNS effects 
result from inhaling  
elem ental mercury.
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□  The Gl tract and, later, the 
kidneys are affected by 
ingestion of mercury salts.
□  Symptoms due to MeHg 
ingestion typically are non­
specific and delayed.
□  Tremor and personality 
disturbances are 
characteristic signs of 
chronic exposure to 
elemental mercury vapor.
due to pulmonary dysfunction. Conjunctivitis and an erythematous, 
pruritic rash have been reported with relatively mild exposures to 
mercury vapor. Ingested liquid elemental mercury is not absorbed 
well and therefore poses only limited risk of toxicity. Contact with 
liquid mercury has been associated with a dermatitis characterized 
by a papular erythema.
Mercury Salts
The acute lethal dose of most mercury salts is approximately 1 to 4 g 
for adults. Symptoms and signs a few hours after ingestion include 
a metallic taste in the mouth; nausea, vomiting, and bloody diarrhea; 
severe abdominal pain; tenesmus; intestinal wall necrosis leading to 
scarring, fibrosis, and possible stenosis; hematemesis; and cardio­
vascular collapse due to dehydration. The urine may contain protein, 
casts, and red blood cells. One day to two weeks after ingestion, 
urine output may diminish due to acute tubular necrosis. Death due 
to uremia may result.
Organic Mercury
The neurologic effects of MeHg ingestion have been well docu­
mented after outbreaks of poisoning in Minamata, Japan, (where fish 
containing MeHg was consumed) and in Iraq (where grain treated 
with a MeHg fungicide was consumed). In adults, the earliest signs 
and symptoms are nonspecific and can take months to develop. 
These include ataxia; paresthesias; malaise; blurred vision; and 
impaired hearing, taste, and smell. In Japan, the neurologic effects 
of MeHg were first observed in cats who ate the mercury-contami­
nated fish, leading to the colloquialism "cat dancing disease."
The signs and symptoms of poisoning due to aryl organomercury 




The most important effects of chronic exposure to elemental mercury 
vapor involve the nervous system. At chronic low doses, the body 
oxidizes most of the elemental mercury to mercuric ions (Hg2+), 
which do not readily cross the blood-brain barrier. At high doses, the 
body is not able to metabolize the mercury rapidly enough and more 
elemental mercury reaches the brain. CNS signs and symptoms 
include psychological changes, insomnia, loss of appetite with 
weight loss, erethism (characterized by insomnia, excessive shy­
ness, and emotional instability), irritability, headache, and short-term 
memory loss.
Tremor, though seldom the first sign to appear, is characteristic of 
exposure; it usually disappears if exposure is stopped. Other periph­
eral nervous system findings include distal paresthesias, motor and 
sensory nerve conduction delay, and limb weakness.
Mercury Toxicity
Acrodynia, a rare syndrome characterized by severe leg cramps; 
irritability; paresthesias; and painful pink fingers and peeling hands, 
feet, and nose, may develop in children exposed to elemental 
mercury, mercury salts, or phenylmercury (which is rapidly metabo­
lized to Hg2+). It is not known why children but not adults are affected 
by acrodynia. It is also an enigma why few children exposed to 
mercury develop acrodynia. If one case is diagnosed, it is likely that 
other persons have been exposed.
Mercury Salts
According to two case reports, the chronic ingestion of mercury salts 
in the form of a laxative resulted in irritability, colitis, and chronic renal 
failure. Gingivitis, stomatitis, and salivation also can occur.
Organic Mercury
The signs and symptoms of chronic exposure to MeHg include a 
tingling sensation in the extremities; tunnel vision; impaired hearing, 
taste, and smell; incoordination; tremor; irritability; memory loss; 
depression; and insomnia. As with acute MeHg exposure, the effects 
of chronic exposure may be delayed for months. Chronic exposure 
to MeHg may result in permanent CNS damage.
Laboratory Tests 
Direct Biologic Indicators
Mercury can be measured in blood, urine, and hair. Since mercury 
has a short half-life in blood (3 days), blood analysis is typically 
performed shortly after an acute exposure; urine is the best biologic 
specimen when chronic mercury exposure is suspected. Hair analy­
sis can provide evidence of MeHg exposure.
For acute high-level mercury exposure, whole blood is a valid 
indicator of body burden (and brain concentration of MeHg); for low- 
level exposure, plasma should be analyzed separately. Blood samples 
should be collected in vacutainers containing heparin and then 
refrigerated. In unexposed adults, the blood mercury level rarely 
exceeds 1.5 micrograms per deciliter (ng/dL); a blood concentration 
of 5 ng/dL or greater is considered the threshold for symptoms of 
toxicity.
A 24-hour urine specimen collected in an acid-washed plastic 
container is the preferred specimen for patients who have been 
chronically exposed to elemental mercury or mercury salts. A first 
morning void can provide a close approximation of a 24-hour 
collection, particularly if it is adjusted for the concentration of the 
urine (using specific gravity or amount of creatinine present). Since 
organic mercury is usually excreted through the biliary system, urine 
levels are not useful in evaluating MeHg exposure.
□  Permanent CNS damage may 
result from chronic exposure 
to MeHg.
□  Blood is an appropriate 
specimen for analysis after 
acute mercury exposure; a 
24-hour urine specimen is 
preferred in cases of 
chronic exposure.
□  In adults, the background 
mercury concentration is 
generally less than
1.5 pg/dL in blood and 
less than 20 |ug/L in urine.
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Urine should be analyzed for mercury by cold vapor atomic absorp­
tion spectrophotometry. The Reinsch test, a screening test for heavy 
metals, is not sufficiently specific or sensitive to detect low levels of 
mercury. A urinary mercury concentration of less than 20 (ag/L in 
adults is considered background. Urine mercury concentrations 
from 20 to 100 |ag/L are associated with subtle changes on some 
tests, even before overt symptoms occur (Table 2). Background or 
toxic urinary mercury concentrations have not been determined for 
children.
Generally, levels of mercury in hair are not useful in evaluating a 
patient clinically. A properly handled hair sample can provide evi­
dence of MeHg exposure because MeHg accumulates in hair where 
its concentration remains constant. Maternal hair samples have 
been used to provide an estimate of fetal MeHg exposure.







20 to 100 Decreased response on tests for 
nerve conduction, brain-wave 
activity, and verbal skills 
Early indication of tremor on 
testing
100 to 500 Irritability, depression, memory 
loss, minor tremor, and other 
nervous system disturbances 
Early signs of disturbed kidney 
function
500 to 1000 Kidney inflammation 
Swollen gums
Significant tremor and nervous 
system disturbances
Indirect Biologic Indicators
If acute inorganic mercury poisoning is suspected, baseline BUN, 
creatinine, electrolytes, and urinalysis should be obtained; these 
values should be monitored continually to evaluate renal toxicity. 
Urinary B2-microglobulin and retinol-binding protein levels may be 





(4) What problem list could you construct for the patient in the case study?
(5) What is your differential diagnosis?
(6) What tests would you order to confirm or rule out your diagnoses?
Treatment and Management
The treatment of inorganic mercury poisoning usually involves the 
use of chelating agents. Chelating agents contain sulfhydryl groups, 
which bind mercury ions and facilitate their excretion through urine 
and feces. Dimercaprol (British anti-Lewisite or BAL) was the first 
chelating agent used for mercury toxicity and is still widely used for 
inorganic mercury poisoning. BAL is contraindicated for MeHg 
poisoning because it has been shown to increase the concentration 
of MeHg in the brain and therefore exacerbates symptoms. BAL is 
anticipated to be effective in treating phenylmercury poisoning 
because phenylmercuric acetate is rapidly oxidized to Hg2+ in the 
body; hence, phenylmercury is similar to inorganic mercury. Pos­
sible side effects of BAL include nausea and vomiting, headache, 
tachycardia, fever, conjunctivitis, blepharospasm, and lacrimation.
In some cases, an alternative or adjunct to parenterally administered 
BAL is orally administered N-acetylpenicillamine (NAP). Side effects 
of NAP can include fever, rash, leukopenia, eosinophilia, and 
thrombocytopenia.
□  Chelation therapy has been 
used successfully in treating 
patients who have ingested 
mercury salts or inhaled 
elemental mercury.
□  No antidote exists for patients 
poisoned with organic 




□  Acute inhalation of mercury 
vapor may require chelation.
□  Ingestion of elemental 
mercury in amounts typically 
found in thermometers does 
not usually require treatment.
□  Chelation therapy is
recommended for serious 
systemic intoxication due 
to mercury salt ingestion.
Newer derivatives of BAL, such as dimercaptosuccinic acid (DMSA) 
and 2,3-dimercaptopropane-1-sulfonate (DMPS), are more effec­
tive than BAL in experimental studies. DMSA (Succimer™*) is 
available in the United States; consult your regional certified poison 
control center or a physician experienced in chelation therapy for 
more information. DMPS is still an investigational drug and must be 
used under FDA guidelines. When DMPS was administered to two 
workers exposed to high levels of elemental mercury vapor, it 
decreased the mercury excretion half-life from 33.1 days to 11.2 
days.
Elemental Mercury
Patients who have experienced acute elemental mercury inhalation 
should receive supportive care; give supplemental oxygen as needed 
and monitor closely for development of acute pneumonitis and 
pulmonary edema. Chelation may be required.
Elemental mercury is usually nontoxic when ingested; the amount 
contained in a clinical thermometer typically presents little risk. In 
some circumstances, increased or enhanced absorption after a 
relatively small dose may occur in patients with inflammatory bowel 
disease. Rarely, mercury becomes trapped in the appendix or 
intestine and requires surgical removal.
To clean up a spill of metallic mercury, an ordinary household 
vacuum cleaner is of little use and may be harmful since it will 
vaporize the mercury and increase the airborne mercury concentra­
tion. Professional toxic clean-up with a self-contained vacuum 
system or a mercury clean-up kit should be used. Contaminated 
carpeting or porous tile should be discarded after clean-up.
Mercury Salts
When a patient has ingested mercury salts, the goals of therapy are 
to remove mercury from the body and to prevent dehydration and 
shock. Inorganic mercury can be removed from the gastrointestinal 
tract by emesis, catharsis, or lavage. It is imperative that adequate 
intravenous fluids be administered to prevent dehydration and to 
reduce the concentration of mercury in the kidneys. BAL or other 
appropriate chelating agent should be administered immediately; its 
usefulness depends on rapid administration. With a potentially lethal 
mercury dose, early peritoneal dialysis or hemodialysis should be 
considered to enhance mercury removal and to support renal 
function.
* Use of trade names is for identification only and does not imply endorsement by the 
Public Health Service or the U.S. Department of Health and Human Services.
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Organic Mercury
Damage to the nervous system after MeHg exposure is usually 
permanent. Because of evidence that BAL increases the MeHg 
concentration in the brain, BAL (and perhaps other chelating agents) 
should not be used to treat MeHg toxicity. Since sulfhydryl groups 
bind tightly to mercury ions, oral polythiol resin (for mercury inges­
tion) and regional hemodialysis with L-cysteine may be of some 
benefit, but these therapies are unproven. Exchange transfusion 
also has been used in an attempt to reduce the body's mercury 
burden.
CfaCierifle
(7) What treatment would you recommend for the patient in the case study?
(8) What follow-up measures would you recommend for managing this exposure?
Standards and Regulations
The regulations and guidelines pertaining to mercury and mercury 
compounds in air, water, and food are summarized in Table 3.
Workplace
Air
The workroom air standard mandated by the Occupational Safety 
and Health Administration (OSHA) is a time-weighted average 
(TWA) of 6.1 parts per billion (ppb) or 0.05 milligrams per cubic meter 
of air (mg/m3) for inorganic mercury vapor, and 1.2 ppb or 0.01 
mg/m3 for organomercury compounds. NIOSH recommends a con­
centration no greater than 6.1 ppb as a TWA exposure for an 8-hour 
workday. Subjective psychological complaints, subtle decrements in
□  Administration of BAL for 




some neuropsychological and neurophysiologic parameters, and 
the appearance of proteinuria have all been reported to occur after 
exposure to airborne mercury at concentrations as low as 1.2 ppb 
(0.01 mg/m3). Correlating airborne mercury levels with health effects 
is difficult because almost all studies have used area sampling, 




The EPA National Emission Standards for mercury from various 
industrial sources include the following: mercury ore processing 
facilities— 2300 g mercury maximum per 24-hour period; mercury 
cell chlor-alkali plants, sludge incineration plants, other wastewater 
treatments— 3200 g mercury maximum per 24-hour period. Ambi­
ent air contains mercury at about 2.4 parts per trillion (ppt); however, 
concentrations near certain industrial areas, such as mercury mines 
and refineries, can be nearly 1800 ppt.
Water
The World Health Organization (WHO) guideline for all forms of 
mercury in drinking water is 1 ppb (1 jag/L). The EPA standard for 
drinking water is 2 ppb. EPA estimates that, for an adult of average 
weight, exposure to 21 jag of inorganic or organic mercury per day 
in food or water will probably not result in any harm to health. The 
FDA limits mercury in bottled water to 2 ppb.
Food
The FDA regulation for mercury in fish is 1 ppm (1000 ppb). Mercury 
concentrations in most non-fish foodstuffs are generally less than
0.02 ppb, although levels of up to 0.2 ppb have been detected in 
meat and poultry. The average concentration of mercury in most fish 
is less than 0.2 ppb.
Biologic Standards
Mercury is being considered for inclusion in the biological exposure 
indices (BEI) established by the American Conference of Govern­
mental Industrial Hygienists (ACGIH). BEIs are reference values 
intended as workplace guidelines for evaluating potential exposure 
hazards by measuring appropriate determinants in specimens col­
lected from workers at specified times. The proposed BEI for total 
inorganic mercury in urine, collected preshift, is 35 micrograms per 
gram (ng/g) creatinine. The proposed BEI fortotal inorganic mercury 
in blood is 1.5 jag/dL, collected at the end of the workweek.
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Table 3. Standards and regulations for mercury
Agency* Focus Level Comments
ACGIH Air-workplace 
Organo (alkyl) mercury 
compounds 1.2 ppb (0.01 mg/m3) 
3.6 ppb (0.03 mg/m3)
Advisory; TLV-TWA* 
Advisory; STEL5
Mercury vapor 6.1 ppb (0.05 mg/m3) Advisory; TWA
Mercury
(aryl and inorganic) 12 ppb (0.10 mg/m3) Advisory; TWA
NIOSH Air-workplace 6.1 ppb (0.05 mg/m3) Advisory; TWA
OSHA Air-workplace 





1.2 ppb (0.01 mg/m3)
6.1 ppb (0.05 mg/m3)
6.1 ppb (0.05 mg/m3)
Regulation; TWA
EPA Drinking water 2 ppb (2 ng/L) Regulation; MCL1
Air
Mercury ore processing 
Mercury cell,
chlor-alkali plants, sludge 
incineration and wastewater 
treatment plants
2300 g Hg/24-hr period 
maximum




FDA Food and water
Fish 1 ppm 
Bottled drinking water 2 ppb (2 (ag/L)
Regulation
WHO Drinking water 1 ppb (1 |ig/L) Guideline
* ACGIH = American Conference of Governmental Industrial Hygienists; EPA = Environmental Protection Agency; FDA = Food and 
Drug Administration; NIOSH = National Institute for Occupational Safety and Health; OSHA = Occupational Safety and Health 
Administration; WHO = World Health Organization
'  TLV-TWA (Threshold Limit Value-Time-Weighted Average) = a time-weighted average concentration for a normal workday and a 
40-hour workweek to which nearly all workers may be repeatedly exposed.
s STEL (Short-Term Exposure Limit) = a 15-minute TWA exposure which should not be exceeded at any time during a workday.
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Sources of Information
More information on the adverse effects of mercury and the treatment and management of mercury-exposed 
persons can be obtained from ATSDR, your state and local health departments, university medical centers, and 
the National Pesticide Telecommunications Network 24-hour toll-free hotline (1-800-858-7378). Case Studies in 
Environmental Medicine: Mercury Toxicity is one of a series. For other publications in this series, please use the 
order form on the back cover. For clinical inquiries, contact ATSDR, Division of Health Education, Office of the 
Director, at (404) 639-6204.
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Answers to Pretest and Challenge Questions
Pretest
Pretest can be found on page 1.
(a) The patient's problem list includes painful extremities; erythematous and peeling skin on nose, toes, and 
fingers; personality changes; tachycardia; sweating; and possible intermittent low-grade fever.
(b) Diagnoses you might consider are the following:
(1) acute rheumatic fever. ARF occurs most commonly between the ages of 5 and 15 years when strep­
tococcal infection is relatively common. Sore joints and fever are characteristic.
(2) leukemia. This is the most common cancer in young children, and symptoms can include sweats and low- 
grade fever. This diagnosis would not explain the erythematous and peeling skin of the fingers and toes.
(3) Kawasaki disease. The patient does not have some of the common signs of this disease: e.g., he does 
not have bilateral conjunctivitis; lymphadenopathy; a red rash on his body; red and sore lips, mouth, or 
throat. However, he is under 5 years of age and does have red and tender hands and feet with peeling 
skin. He may have had a fever, but it is not well characterized. Kawasaki disease is relatively rare— only 
5 to 10 of every 100,000 children acquire the disease.
(4) tuberculosis. The patient's night sweats and possible low-grade fever make this a possibility; however, 
he has no cough, and tuberculosis is not associated with erythematous and peeling skin on the fingers 
and toes.
(5) measles. Although immunized against measles, the patient could have experienced primary vaccine 
failure. However, he does not have Koplik's spots, cough, conjunctivitis, coryza, or a typical rash, making 
this diagnosis unlikely.
(6) boric acid poisoning. Irritability and erythema and peeling of the skin and mucous membranes can occur 
with boric acid poisoning. However, the patient does not exhibit renal toxicity or other common symptoms 
of boric acid toxicity such as nausea, vomiting, and diarrhea.
(7) acrodynia. The patient exhibits many of the symptoms common to this disease. See the problem list in
(a) above. This disease of infancy and early childhood is caused in most, if not all, instances by exposure 
to mercury.
In addition, Stevens-Johnson syndrome, fifth disease, scarlet fever, rubella, systemic lupus erythematosus, 
and drug rashes (due to an unsuspected ingestion) should be considered.
(c) The best test to confirm or rule out chronic mercury exposure is a 24-hour urinary mercury concentration and 
creatinine clearance. The urine should be analyzed by cold vapor atomic absorption spectrophotometry; the 
Reinsch test— a heavy metal screening test— is not sufficiently specific or sensitive. In addition, the following 
tests would be useful to help exclude other diagnoses in the differential: complete blood count with differential; 
erythrocyte sedimentation rate or C-reactive protein; chest and hip X rays; serum creatinine and blood urea 
nitrogen; urinalysis; tuberculin skin test with controls; streptoccocal antibody titers (ASO); and throat culture 
for streptococcus.
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Answers to Pretest and Challenge Questions
Pretest continued
(d) If test results indicate the patient has a high urinary mercury concentration, che la tion  the rapy should be 
considered, and a physician experienced in chelation therapy should be consulted. It is also important to 
ensure that the patient is no longer exposed to the mercury source.
All family members should have their urinary mercury concentration measured. A common exposure is quite 
likely, particularly if the source is mercury vapor in the home. If the source is a product used in the home, other 
persons using the product may be at risk. The county or state health department should be contacted to identify 
and eliminate the mercury source and to evaluate the potential exposure to members of the community. 
Medical follow-up for m ercury-exposed persons includes monitoring nervous system and renal function 
status.
Challenge
Challenge questions begin on page 4.
(1) In a patient so young, sources of chronic mercury exposure are most likely to be linked to the home. Within 
the home, the possible mercury sources include off-gassing of paint on interior walls and liquid mercury from 
a spill embedded in floors or carpets. Possible ingestion sources include contaminated drinking water,mercury- 
containing medicináis, or folk remedies.
(2) If the mercury source is in the home or diet, all members of the family could be exposed. Other persons in the 
community who ingest contaminated food or drink might also be affected. In addition, if paint is the source of 
exposure, consumers using the same paint brand may be exposed.
(3) Yes, if the source is elemental mercury vapor released from paint in the home, the mother, and subsequently, 
the fetus, are likely to be exposed. Although the adverse developmental effects of MeHg are known, the long­
term neurologic consequences to the human fetus of chronic low-level exposure to mercury vapor have not 
been documented well.
(4) See pretest answer (a).
(5) See pretest answer (b).
(6) See pretest answer (c).
(7) See pretest answer (d).




Continuing education credit is available to health professionals who use this monograph and complete the 
posttest. The criterion for awarding continuing medical education (CME) credits and continuing education units 
(CEU) is a posttest score of 70% or better.
The Centers for Disease Control and Prevention (CDC) is accredited by the Accreditation Council for Continuing 
Medical Education (ACCME) to sponsor continuing medical education for physicians, and by the International 
Association for Continuing Education and Training (IACET) to sponsor continuing education units for other health 
professionals.
The Agency for Toxic Substances and Disease Registry, in joint sponsorship with CDC, is offering 1 hour of CME 
credit in Category 1 of the Physician's Recognition Award of the American Medical Association and 0.1 hour of 
CEU for other health professionals upon completion of this monograph.
In addition, the series Case Studies in Environmental Medicine has been reviewed and is acceptable for credit 
by the following organizations:
The American Academy of Family Physicians (AAFP). This program has been reviewed and is acceptable for 
1 prescribed hour by the American Academy of Family Physicians. (Term of Approval: beginning January 1992.) 
For specific information, please consult the AAFP Office of Continuing Medical Education.
The American College of Emergency Physicians (ACEP). Approved by the American College of Emergency 
Physicians for one hour per issue of ACEP Category I credit.
The American Osteopathic Association (AOA). AOA has approved this issue for 1 credit hour of Category 
2-B credit.
The American Association of Occupational Health Nurses (AAOHN). AAOHN has approved this program for 
1.2 contact hours. Applicant will receive the assigned code number in the award letter.
The American Board of Industrial Hygiene (ABIH). ABIH has approved this program for 0.5 certification 
maintenance (CM) point per 3 Case Studies. The CM approval number is 2817.
To receive continuing education credit (CME or CEUs), complete the Posttest on page 24 in the manner shown 
in the sample question below. Circle all correct answers.
Which of the following is known to precipitate migraine headaches?




After you have finished the Posttest, please transfer your answers to the answer sheet on the inside back cover 
and complete the evaluation on the lower half of that page. Fold, staple, and mail the back cover to Continuing 
Education Coordinator, Agency for Toxic Substances and Disease Registry, Division of Health Education, E33, 
1600 Clifton Road, Atlanta, GA 30333. Your confidential test score will be returned with an indication of where 
the correct answers can be found in the text. Validation of earned CME credit and CEU will also be forwarded to 
participants, and their names, if requested, will be placed on the mailing list to receive other issues in the Case 




Circle all correct answers and transfer your answers to page 25.
1. Which of the following statements about mercury sources is true?
a. Fish consumption is the main source of MeHg exposure in the general population.
b. Ingesting small amounts of elemental mercury is lethal.
c. Burning fossil fuels contributes to the level of mercury in the atmosphere.
d. A mercury spill can be safely cleaned up using a household vacuum cleaner.
e. By law, medicines or over-the-counter preparations can no longer contain mercury in any form.






3. Which of the following statements are true of the mercury in a mercury salt such as mercuric chloride?
a. It is excreted mainly in the bile and feces.
b. It has a whole-body clearance of 3 to 5 days.
c. It will cause only CNS injury.
d. It does not readily cross the blood-brain barrier.
e. It is readily reduced to elemental mercury in the body.






5. Which of the following statements are true about laboratory tests and mercury exposure?
a. The best test to confirm chronic inhalation exposure is a urinary B2-microglobulin level.
b. A chest X ray will reveal deposits of mercury in the lungs up to 5 hours after inhalation exposure.
c. A blood mercury concentration of 20 jag/dL indicates mercury poisoning.
d. Hair analysis is useful in clinically evaluating all mercury-poisoned patients.
e. A urinary mercury concentration of less than 20 jag/L in adults is considered a background level.
6. The standard of care for mercury-poisoned patients may include
a. chelation therapy to reverse neurologic damage caused by MeHg ingestion
b. chelation therapy for a patient who has swallowed a bead of liquid mercury
c. an abdominal X ray for a patient who has recently consumed grain treated with MeHg
d. renal supportive therapy for a patient who has ingested mercuric chloride
e. chelation therapy for a patient who has ingested a significant quantity of mercuric chloride
7. Clinical evidence of mercury poisoning due to ingestion of fish (MeHg form) may include
a. tunnel vision












CASE STUDIES IN ENVIRONMENTAL MEDICINE: MERCURY TOXICITY
If you wish CME credits or CEU, please indicate your answers to the Posttest questions on page 24 by circling 
the letters below for the correct answers. Complete the evaluation questionnaire and fill in the information 
requested on the reverse side. Tear off this last page, fold, staple, and mail to Continuing Education Coordinator, 
Agency forToxic Substances and Disease Registry, Division of Health Education, E 33,1600 Clifton Road, Atlanta, 
GA 30333.
1. a b c d e
2. a b c d e
3. a b c d e
4. a b c d e
5. a b c d e
6. a b c d e
7. a b c d e
8. a b c d e
Evaluation Questionnaire





1. As a result of completing this monograph, I will be able to:
Explain why mercury may be an acute and chronic 
health hazard.
Describe the known factors contributing to mercury toxicity. 
Identify potential environmental or occupational sources of 
exposure to mercury.
Identify evaluation and treatment protocols for persons 
exposed to mercury.
List sources of information on mercury.
2. The monograph addressed the objectives printed on the 
inside front cover.
am more likely to ask patients questions regarding possible 
environmental exposures as a result of reading this issue. 
Independent study was an effective teaching method for 
the content.
How much time (in minutes) was required to read this monograph 
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